These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8767528)

  • 1. Plasma cell P170 expression and response to treatment in multiple myeloma.
    Patriarca F; Melli C; Damiani D; Michieli M; Michelutti A; Cavo M; Baccarani M
    Haematologica; 1996; 81(3):232-7. PubMed ID: 8767528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression.
    Bodey B; Taylor CR; Siegel SE; Kaiser HE
    Anticancer Res; 1995; 15(6B):2461-8. PubMed ID: 8669809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody.
    Tong AW; Lee J; Wang RM; Dalton WS; Tsuruo T; Fay JW; Stone MJ
    Cancer Res; 1989 Sep; 49(17):4829-34. PubMed ID: 2569359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
    Tu Y; Renner S; Xu F; Fleishman A; Taylor J; Weisz J; Vescio R; Rettig M; Berenson J; Krajewski S; Reed JC; Lichtenstein A
    Cancer Res; 1998 Jan; 58(2):256-62. PubMed ID: 9443402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma].
    Luo SK; Li J; Hong WD; Zhao Y; Tong XZ
    Ai Zheng; 2005 Dec; 24(12):1518-21. PubMed ID: 16351805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of the multidrug transporter P-170 glycoprotein in remission phase is associated with early and resistant relapse in multiple myeloma.
    Musto P; Lombardi G; Matera R; Carotenuto M
    Haematologica; 1991; 76(6):513-6. PubMed ID: 1687943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia.
    Savignano C; Geromin A; Michieli M; Damiani D; Michelutti A; Melli C; Fanin R; Baccarani M
    Haematologica; 1993; 78(5):261-3. PubMed ID: 7906239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin A derivatives.
    Michieli M; Damiani D; Michelutti A; Melli C; Russo D; Fanin R; Baccarani M
    Haematologica; 1994; 79(2):119-26. PubMed ID: 7914881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer chemotherapy does not enhance MDR-associated 170 kd glycoprotein expression in normal blood mononuclear cells.
    Geromin A; Michieli M; Damiani D; Michelutti A; Vigevani E; Signor M; Fanin R; Baccarani M
    Haematologica; 1992; 77(6):470-2. PubMed ID: 1363234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein expression and prognostic value in acute myeloid leukemia.
    Senent L; Jarque I; Martín G; Sempere A; González-García Y; Gomis F; Pérez-Sirvent M; De La Rubia J; Sanz MA
    Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
    Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia.
    Michieli M; Damiani D; Geromin A; Michelutti A; Fanin R; Raspadori D; Russo D; Visani G; Dinota A; Pileri S
    Eur J Haematol; 1992 Feb; 48(2):87-92. PubMed ID: 1347749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoresistance and multiple myeloma: from biological to clinical aspects.
    Rossi JF
    Stem Cells; 1995 Aug; 13 Suppl 2():64-71. PubMed ID: 8520514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multidrug resistance gene (MDR-1) in human normal leukocytes.
    Damiani D; Michieli M; Michelutti A; Geromin A; Raspadori D; Fanin R; Savignano C; Giacca M; Pileri S; Mallardi F
    Haematologica; 1993; 78(1):12-7. PubMed ID: 8098310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes in t(4;14) multiple myeloma: a chemotherapy-sensitive disease characterized by rapid relapse and alkylating agent resistance.
    Jaksic W; Trudel S; Chang H; Trieu Y; Qi X; Mikhael J; Reece D; Chen C; Stewart AK
    J Clin Oncol; 2005 Oct; 23(28):7069-73. PubMed ID: 16129840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance in multiple myeloma.
    Sonneveld P
    Pathol Biol (Paris); 1999 Feb; 47(2):182-7. PubMed ID: 10192886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique human ovarian carcinoma cell line expressing CD34 in association with selection for multidrug resistance.
    Minderman H; Vanhoefer U; Toth K; Minderman MD; Rustum YM
    Cancer; 1996 Dec; 78(11):2427-36. PubMed ID: 8941015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance in multiple myeloma.
    Sonneveld P; Lokhorst HM; Vossebeld P
    Semin Hematol; 1997 Oct; 34(4 Suppl 5):34-9. PubMed ID: 9408959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.